Neuroloxía
Servicio
Celia
Oreja Guevara
Publicacións nas que colabora con Celia Oreja Guevara (36)
2024
-
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study
Multiple Sclerosis and Related Disorders, Vol. 90
-
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside Attacks
Neurology, Vol. 103, Núm. 6
-
Multiple sclerosis: Pregnancy, fertility, and assisted reproductive technology–a review
Multiple Sclerosis and Related Disorders, Vol. 92
2023
-
Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel
Neurology and Therapy, Vol. 12, Núm. 2, pp. 427-439
2022
-
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
Frontiers in immunology, Vol. 13, pp. 842354
-
Consensus on early detection of disease progression in patients with multiple sclerosis
Frontiers in Neurology, Vol. 13
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
2021
-
Non-inflammatory causes of emergency consultation in patients with multiple sclerosis
Neurologia, Vol. 36, Núm. 6, pp. 403-411
-
SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry
Neurology(R) neuroimmunology & neuroinflammation, Vol. 8, Núm. 5
-
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (I)
Revista de neurologia, Vol. 72, Núm. 11, pp. 397-406
-
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (II)
Revista de neurologia, Vol. 72, Núm. 12, pp. 433-442
2017
-
Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation
Brain and Behavior, Vol. 7, Núm. 4
-
Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 18, pp. 71-76
-
Revisión de las novedades del XXXII Congreso ECTRIMS 2016, presentadas en la IX Reunión Post-ECTRIMS (II)
Revista de Neurologia, Vol. 65, Núm. 2, pp. 75-84
-
Revisión de las novedades del XXXII congreso ectrims 2016, presentadas en la ix reunión post-ectrims (I)
Revista de Neurologia, Vol. 65, Núm. 1, pp. 31-40
2016
-
Analysis of the relationship between the month of birth and risk of multiple sclerosis in a Spanish population
European Neurology, Vol. 76, Núm. 5-6, pp. 202-209
-
Respuesta al tratamiento con interferón beta en pacientes con esclerosis múltiple. Validación del Rio Score
Revista de Neurologia, Vol. 63, Núm. 4, pp. 145-150
-
Revisión de las novedades del XXXI Congreso ECTRIMS 2015, presentadas en la VIII Reunión Post-ECTRIMS
Revista de Neurologia, Vol. 62, Núm. 12, pp. 559-569
2015
-
Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis
Revista de Neurologia, Vol. 61, Núm. 4, pp. 145-152
-
Consenso español actualizado sobre el uso del natalizumab (Tysabri®)-2013
Neurologia, Vol. 30, Núm. 5, pp. 302-314